デフォルト表紙
市場調査レポート
商品コード
1493317

慢性腎臓病向け臨床栄養市場の市場規模、シェア、動向分析レポート:製品別、段階別、販売チャネル別、地域別、セグメント別予測、2024年~2030年

Clinical Nutrition For Chronic Kidney Diseases Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 125 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
慢性腎臓病向け臨床栄養市場の市場規模、シェア、動向分析レポート:製品別、段階別、販売チャネル別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年05月24日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

慢性腎臓病向け臨床栄養市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、慢性腎臓病向け臨床栄養の世界市場規模は2030年までに23億7,000万米ドルに達し、市場推計期間中にCAGR 6.03%で成長すると予測されています。

世界的に、CKDは重大な死因として浮上しており、過去20年間に死亡率が上昇した稀な非伝染性疾患の一つです。

CKDの世界の罹患率の上昇により、CKD患者特有の栄養補助食品に対するニーズが高まり、さまざまな栄養補助食品が開発されるようになった。この動向は、CKDを患う人々の腎臓の健康と全体的な健康を促進する効率的で安全なサプリメントの開発における継続的な研究と技術革新の重要性を強調しています。

このような欠乏症を治療しようという人々やヘルスケア専門家の意識が高まるにつれて、経口臨床栄養製品に対する需要が高まっています。天然化合物や栄養補助食品の調査により、市場成長の余地が広がっています。顕著な例としては、多価不飽和脂肪酸、植物ステロール、フェノール化合物からなる栄養補助食品が挙げられます。さらに、レスベラトロールやクルクミンなどの植物由来化合物は、酸化ストレスを軽減する効果があることが証明されており、CKDの進行とそれに伴う心血管系の脅威を遅らせることができます。

経腸栄養デバイスなどの関連産業における技術の進歩は、市場成長にプラスの影響を与えます。主要企業は経腸投与が可能な製品を発売しており、市場成長を後押ししています。さらに、承認という形で政府の支援が予測期間中の市場成長を促進すると予想されます。

慢性腎臓病向け臨床栄養市場レポート・ハイライト

  • 不健康なライフスタイルは、栄養不足、肥満、慢性疾患、神経疾患、自己免疫疾患の増加につながる免疫力の低下などの健康問題の負担増につながっています。
  • 合併、提携、パートナーシップ、製品拡大が市場を特徴付け、市場成長を促進します。
  • 経口栄養剤は2023年に50%以上のシェアを占め、製品セグメントを支配しています。しかし、非経口処方は将来的に有利な成長を記録すると予測されています。
  • 成人は85%の売上シェアでステージセグメントをリードしています。成人の年齢層では、特に30歳以上の女性の間で、筋力の低下、ビタミンやカルシウムの欠乏を経験する人が増えており、これがこのセグメントの成長につながった。
  • 遠隔医療の進歩により、臨床栄養製品の世界の流通が可能になり、メーカーは市場範囲を広げ、十分なサービスを受けていない地域にも対応できるようになった。そのため、オンライン販売は予測期間にわたって市場の成長を大きく助けると期待されています。
  • アジア太平洋地域は、同地域における製造施設の増加や一人当たり医療費の増加により、予測期間中に7%近い最速のCAGRを記録すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 慢性腎臓病向け臨床栄養に関する世界の市場変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
    • 市場機会分析
  • 慢性腎臓病の世界臨床栄養市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 慢性腎臓病向け臨床栄養の世界市場:製品推定・動向分析

  • 慢性腎臓病向け臨床栄養に関する世界市場:製品ダッシュボード
  • 慢性腎臓病向け臨床栄養の世界市場:製品変動分析
  • 慢性腎臓病向け臨床栄養の市場規模と予測および動向分析、2018年から2030年まで
  • 経口栄養
  • 経腸栄養
  • 経腸栄養剤

第5章 慢性腎臓病向け臨床栄養市場:段階的推定・動向分析

  • 慢性腎臓病向け臨床栄養市場:段階ダッシュボード
  • 慢性腎臓病向け臨床栄養市場:段階変動分析
  • 慢性腎臓病向け臨床栄養の市場規模と予測および動向分析、2018年から2030年まで
  • 成人
  • 小児

第6章 慢性腎臓病向け臨床栄養の世界市場:販売チャネルの推定・動向分析

  • 慢性腎臓病向け臨床栄養の世界市場:販売チャネルダッシュボード
  • 慢性腎臓病向け臨床栄養の世界市場:販売チャネル変動分析
  • 慢性腎臓病向け臨床栄養の市場規模と予測および動向分析、2018年から2030年まで
  • オンライン
  • 小売り
  • 機関投資家向け販売

第7章 慢性腎臓病向け臨床栄養の世界市場:地域推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模、予測動向分析、2018年から2030年:
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要ディストリビューターおよびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • Abbott Nutrition
    • Pfizer Inc.
    • Bayer AG
    • Nestle Health Science SA
    • GlaxoSmithKline plc
    • Baxter International Inc.
    • Otsuka Holdings Co., Ltd.
    • Mead Johnson &Company, LLC
    • Danone Nutricia
    • Victus, Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global clinical nutrition for chronic kidney diseases market, 2018 - 2030 (USD Million)
  • Table 3 Global clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 5 Global clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 6 North America clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 9 North America clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 12 U.S. clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 15 Canada clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 16 Europe clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 20 UK clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 22 UK clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 23 Germany clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 25 Germany clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 26 France clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 27 France clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 28 France clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 29 Italy clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 30 Italy clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 31 Italy clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 32 Spain clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 33 Spain clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 34 Spain clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 35 Denmark clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 36 Denmark clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 37 Denmark clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 38 Sweden clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 40 Sweden clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 41 Norway clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 43 Norway clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 48 China clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 49 China clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 50 China clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 51 Japan clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 53 Japan clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 54 India clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 55 India clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 56 India clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 57 Australia clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 58 Australia clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 59 Australia clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 60 Thailand clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 61 Thailand clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 62 Thailand clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 63 South Korea clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 65 South Korea clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 66 Latin America clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 68 Latin America clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 69 Latin America clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 70 Brazil clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 71 Brazil clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 72 Brazil clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 73 Mexico clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 74 Mexico clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 75 Mexico clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 78 Argentina clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 79 MEA clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 82 MEA clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 85 South Africa clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 89 UAE clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 91 UAE clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
  • Table 94 Kuwait clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Clinical nutrition for chronic kidney diseases market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Product and stage segment snapshot
  • Fig. 11 Sales channel segment snapshot
  • Fig. 12 Market dynamics
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 PESTLE analysis
  • Fig. 15 Clinical nutrition for chronic kidney diseases market: Product outlook and key takeaways
  • Fig. 16 Clinical nutrition for chronic kidney diseases market: Product movement analysis
  • Fig. 17 Oral nutrition market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Parenteral nutrition market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Enteral feeding formulas market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Clinical nutrition for chronic kidney diseases market: Stage outlook and key takeaways
  • Fig. 21 Clinical nutrition for chronic kidney diseases market: Stage movement analysis
  • Fig. 22 Adult market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Clinical nutrition for chronic kidney diseases market: Sales channel outlook and key takeaways
  • Fig. 25 Clinical nutrition for chronic kidney diseases market: Sales channel movement analysis
  • Fig. 26 Online market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Retail market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Clinical nutrition for chronic kidney diseases market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways (1/2)
  • Fig. 31 Regional marketplace: Key takeaways (2/2)
  • Fig. 32 North America clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 UK clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Germany clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 France clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Italy clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Spain clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Denmark clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Sweden clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Norway clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Asia Pacific clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Japan clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Latin America clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Brazil clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Mexico clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Argentina clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 MEA clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Company market share analysis, 2023
  • Fig. 89 Strategic framework
目次
Product Code: GVR-4-68040-281-1

Clinical Nutrition For Chronic Kidney Diseases Market Growth & Trends:

The global clinical nutrition for chronic kidney diseases market size is estimated to reach USD 2.37 billion by 2030, growing at a CAGR of 6.03% during the forecast period, according to a new report by Grand View Research, Inc. chronic kidney diseases (CKDs) present a substantial challenge, notably in low- and middle-income countries that lack adequate resources for effective management. Globally, CKD has emerged as a significant cause of death and is one of the rare non-communicable diseases experiencing an increase in mortality rates over the past two decades.

The rising global incidence of CKDs has led to the creation of a diverse array of nutritional supplements designed to address the specific dietary needs of CKD patients. This trend emphasizes the significance of continuous research and innovation in developing efficient and secure supplements that promote kidney health and overall well-being for individuals suffering from CKD.

The increasing awareness among the people and healthcare professionals to treat such deficiencies has resulted in the rising demand for oral clinical nutrition products. Research in natural compounds and nutraceuticals has expanded the scope for market growth. Some prominent examples include nutraceuticals comprising polyunsaturated fatty acids, phytosterols, and phenolic compounds. Moreover, plant-derived compounds such as resveratrol and curcumin have been proven effective in reducing oxidative stress, thus slowing CKD progression and the consequent cardiovascular threats.

Technological advancements in allied industries, such as enteral feeding devices, positively impact market growth. Key players are launching products that can be administered through the enteral route, propelling the market growth. Furthermore, government support in the form of approvals is anticipated to fuel the market growth over the forecast period.

Clinical Nutrition For Chronic Kidney Diseases Market Report Highlights:

  • Unhealthy lifestyles have led to the increasing burden of health issues such as lack of nutrition, obesity, poor immunity leading to the rise of chronic, neurological and autoimmune diseases.
  • Mergers, collaborations, partnerships, and product expansions characterize the market and propel market growth.
  • Oral nutrition dominated the product segment with a share of over 50% in 2023; however, parenteral formulas are anticipated to register lucrative growth in the future.
  • Adults led the stage segment with a revenue share of 85%. Individuals in the adult age group are increasingly experiencing decreased muscle strength, vitamin and calcium deficiencies, particularly among women over 30 years old, which has led to the segment growth.
  • Advancements in telemedicine have enabled the global distribution of clinical nutrition products, allowing manufacturers to broaden their market reach and cater to underserved communities. Thus, online sales are expected to aid market growth greatly over the forecast period.
  • Asia Pacific is anticipated to register the fastest CAGR of nearly 7% over the forecast period, owing to the increasing manufacturing facilities in the region and increased per capita healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Stage
    • 1.2.3. Sales Channel
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Stage Outlook
    • 2.2.3. Sales Channels Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Clinical Nutrition for Chronic Kidney Diseases Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Estimates & Trend Analysis

  • 4.1. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Dashboard
  • 4.2. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Movement Analysis
  • 4.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4. Oral Nutrition
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Parenteral Nutrition
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Enteral Feeding Formulas
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Estimates & Trend Analysis

  • 5.1. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Dashboard
  • 5.2. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Movement Analysis
  • 5.3. Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. Adult
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Pediatric
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Estimates & Trend Analysis

  • 6.1. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Dashboard
  • 6.2. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Movement Analysis
  • 6.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Online
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Institutional Sales
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Clinical Nutrition for Chronic Kidney Diseases Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Denmark
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Norway
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. China
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Thailand
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott Nutrition
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Pfizer Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bayer AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Nestle Health Science S.A.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. GlaxoSmithKline plc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Baxter International Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Otsuka Holdings Co., Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mead Johnson & Company, LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Danone Nutricia
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Victus, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives